Effects of BPA on Insulin & Glucose Responses

Status Completed

Clinical Trial Summary

The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral ingestion of BPA impacts insulin and glucose concentrations, and other endocrine factors (Pro-insulin, C-Peptide, Estrogen, triglycerides). Findings from this pilot study will inform public health recommendations for food packaging and provide much needed experimental evidence as to whether BPA poses any public health risk.

Clinical Trial Description

The prevalence of diabetes is well established affecting >29 million Americans with 90-95% of these individuals diagnosed with type 2 diabetes. The etiology of type 2 diabetes is not fully understood, but clearly diet, physical activity, and genetics play roles. Emerging data suggests a novel hypothesis that synthetic non-persistent endocrine disruptors used in a variety of common consumer goods, including the industry-produced chemical bisphenol A (BPA) play a pivotal role in type 2 diabetes and obesity rates. In support of this hypothesis, National Health and Nutrition Examination Survey (NHANES), Nurses' Health Study II (NHSII), and other cross-sectional data have shown associations between urinary BPA concentrations and type-2 diabetes, pre-diabetes, insulin resistance, and hemoglobin A1c. The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral ingestion of BPA impacts insulin and glucose concentrations, and other endocrine factors (Pro-insulin, C-Peptide, Estrogen, triglycerides) in the pathogenesis of Type 2 diabetes and cardiovascular disease. Findings from this pilot study will inform public health recommendations for food packaging and provide much needed experimental evidence as to whether BPA poses any public health risk. ;

Study Design

Related Conditions & MeSH terms

Environmental Exposure

Clinical Trial Details

NCT number	NCT03444922
Study type	Interventional
Source	California Polytechnic State University-San Luis Obispo
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2016
Completion date	February 14, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05541653` - The IGNITE Study on Concentrated Investment in Black Neighborhoods	N/A
Completed	`NCT04028791` - Sickle Cell Trait and Exercise, Effect of Hot Environment	N/A
Not yet recruiting	`NCT05105386` - The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
Completed	`NCT05507944` - FeNO Hairdressers Pilot
Completed	`NCT04146025` - Nurtured in Nature	N/A
Recruiting	`NCT05179993` - Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
Recruiting	`NCT03319927` - Reducing Pesticide Exposures in Child Care Centers	N/A
Recruiting	`NCT05500690` - Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies	N/A
Recruiting	`NCT05394363` - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed	`NCT00021658` - Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health	N/A
Not yet recruiting	`NCT05315388` - Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá	N/A
Recruiting	`NCT06107933` - Developmental Impacts of Microplastics Exposure in Early Life
Completed	`NCT03631667` - Ultralow Dose PAH Binary Mixture Study	Early Phase 1
Completed	`NCT02540408` - Detection and Characterization of COPD in Dairy Farmers	N/A
Completed	`NCT03440307` - Intervention to Reduce Bisphenol A Exposure in Women	N/A
Completed	`NCT05160948` - Change in Knowledge After Receiving Personal Air Pollution Results
Not yet recruiting	`NCT05865782` - Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes	N/A
Completed	`NCT02707172` - Removal of Dermal Exposure to Phthalate Ester by Hand Washing	N/A
Active, not recruiting	`NCT03215368` - The Ma'Anshan Birth Cohort (MABC)
Recruiting	`NCT06083415` - Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of BPA on Insulin and Glucose Responses

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms